Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 111 followers
Latest posts
Last updated about 9 hours ago
Agenda of the PRAC meeting 27 - 30 October 2025
about 9 hours ago
Agenda of the PRAC meeting 27 - 30 October 2025
Human medicines European public assessment report (EPAR): Fanskya, Mozafancogene autotemcel, Status: Application withdrawn
about 9 hours ago
Human medicines European public assessment report (EPAR): Fanskya, Mozafancogene autotemcel, Status: Application...
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 5, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 43, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 26, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 36, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 8, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Elzonris, tagraxofusp, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Elzonris, tagraxofusp, Date of authorisation...
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation: 17/09/2025, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation...